Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...

To be sure, some goods will not be subject to the reciprocal tariff. They include steel and aluminum articles and autos and ...

VanEck Pharma ETF (PPH) which represents Big Pharma rises despite ongoing industry specific challenges as pharmaceuticals are ...

Bangalore: AstraZeneca Pharma India Limited has announced that the Company will be discontinuing the manufacturing and ...

As per Geojit Investments report, Zydus Lifesciences' 47 percentage of revenue comes from the US. Similarly, Aurobindo Pharma ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.

Nifty Pharma took a beating on Friday declining over four per cent, after Donald Trump hinted at a separate tariff for ...

Tariffs will trigger some job losses, and impact future investment, but Ireland’s strategic value remains solid - ‘Pharma isn ...

But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...

boosting their US manufacturing presence to avoid a potential 25% tariff on imported pharma products. Although World Trade Organization rules exempt most pharmaceuticals and their starting ...